Knights-Modak Developments Ltd.

	Page
Balance Sheet	1
Notes to the Financial Statements	2

Registered number: 06271302

		2025		2024
	Notes	£	£	£	£
CURRENT ASSETS
Cash at bank and in hand		100		100

		100		100
Creditors: Amounts Falling Due Within One Year	5	(150,466 )		(150,466 )

NET CURRENT ASSETS (LIABILITIES)			(150,366 )		(150,366 )

TOTAL ASSETS LESS CURRENT LIABILITIES			(150,366 )		(150,366 )

NET LIABILITIES			(150,366 )		(150,366 )

CAPITAL AND RESERVES
Called up share capital	6		100		100
Profit and Loss Account			(150,466 )		(150,466 )

SHAREHOLDERS' FUNDS			(150,366)		(150,366)

For the year ending 31 December 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

R Modak

Director

20/09/2026

The notes on page 2 form part of these financial statements.

1. General Information

Knights-Modak Developments Ltd. is a private company, limited by shares, incorporated in England & Wales, registered number 06271302 . The registered office is 463 Wellington Road South, Hounslow, Middlesex, TW4 5HY.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Financial Instruments

Trade and other payables

Trade and other payables are measured at their transaction price unless the arrangement constitutes a financing transaction in which case the transaction is measured at present value of future payments discounted at prevailing market rate of interest. Other financial liabilities are initially measured at fair value net of their transaction costs. They are subsequently measured at amortised cost using the effective interest method.

Cash at bank

Cash at bank in the balance sheet comprise cash at banks and in hand and short term deposits with an original maturity date of three months or less.

Trade and other receivables

Trade and other receivables are measured at transaction price less any impairment unless the arrangement constitutes a financing transaction in which case the transaction is measured at the present value of the future receipts discounted at the prevailing market rate of interest . Loans are initially measured at fair value and are

subsequently measured at amortised cost using the effective interest method less any impairment.

2.3. Going concern

In accordance with their responsibilities as directors, the directors have considered the appropriateness of the going concern basis for the preparation of the financial statements. The company's balance sheet shows net liabilities at the year end and in these circumstances the company's activities are support by its holding company.

The directors have no reason to believe that this support will not continue and have a reasonable expectation that the company has adequate resources to continue in existence for a period of one year from the date of approval of the financial statements.

3. Average Number of Employees

Average number of employees, including directors, during the year was: 2 (2024: 2)

5. Creditors: Amounts Falling Due Within One Year

	2025	2024
	£	£
Amounts owed to group undertakings	150,466	150,466

The company is a subsidiary of Genmed Capital Management Limited.

6. Share Capital

	2025	2024
	£	£
Allotted, Called up and fully paid	100	100

Page 2